Topline A Chinese pharmaceutical company is seeking approval to market Jiyoutai, an alternative to Ozempic that could be the first biosimilar drug to compete with Novo Nordisks weight-loss and diabetes drugs in China ahead of a potential flood of new obesity medicines in the countryespecially as Novo Nordisks patent is set to expire in 2026
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study
The added Collagen aims to improve skin elasticity, hydration, and firmness, complementing the boosters overall focus on a radiant, youthful appearance
Always consult with your doctor or a registered dietitian before making changes to your diet, especially if youre managing a health condition or taking medication, such as semaglutide
Well talk about the benefits of vitamin shots and differences and which might be the better choice depending on your needs
This TB-500 transdermal format combined with BPC-157 offers researchers unprecedented convenience while maintaining scientific rigor